News Headlines Article

Senate panel favors lighter touch for PBM regulation
Modern Healthcare

A Senate Finance Committee hearing on Tuesday signaled a softer take than the Trump administration when it comes to regulating pharmacy benefit managers and their role in the drug supply chain.

Lawmakers questioning executives of five major PBMs showed waning enthusiasm for HHS’ proposed ban on PBM rebates within Medicare Part D.

Senators focused their criticisms on the system’s opaqueness and urged more transparency, steering clear of proposals to expand the Trump administration’s proposed rule to the commercial sector.